Coordinated Services and Access to Research for Women, Infants, Children, and Youth

 

Part D (base): The purpose of this program is to provide family-centered care in the outpatient or ambulatory care setting (directly or through contracts or MOU) to low income, uninsured, and medically underserved women (25 years and older) with HIV, infants (up to two years of age) exposed to or with HIV, children (ages two to 12) with HIV, and youth (ages 13 to 24) with HIV and additional support services to affected family members. Part D (supplemental): The purpose of the Ryan White HIV/AIDS Program Part D -- Women, Infants, Children, and Youth (WICY) Grants Supplemental Funding is to strengthen organizational capacity to respond to the changing health care landscape and to increase capacity to develop, enhance, or expand access to high quality family-centered care services for low income, uninsured, and underserved WICY with HIV.

Active 93.153 Health Resources and Services Administration, Department of Health and Human Services B - Project Grants Fiscal Year 2021 Over 74,000 WICY clients received services funded by RWHAP Part D
Fiscal Year 2023 In FY 2023, the coordination or integration of HIV primary care with behavioral health care, gender-affirming care and telehealth were new activities funded under the Part D WICY Supplemental program. The Enhancing HIV Care of Women, Infants, Children and Youth Building Capacity through Communities of Practice (CoP) contract kicked off on September 30, 2022 with Bizzell US as the contract awardee. In FY 2023 of the contract, fifteen RWHAP Part D recipients (8 Part D only and 7 Parts C/D) were selected to participate in the CoP and all fifteen continue to receive tailored technical assistance through monthly leadership calls, learning sessions and cross collaboration. In FY 2023, the Part D WICY Basic Training program has implemented two sessions thus far on Comprehensive, Coordinated System of Care Program Requirements and Part D Fiscal Requirements. An estimated total of 544 participants listened in on both sessions. 42 U.S.C. 300ff-71, 300f-121 Public and nonprofit private entities (including a health facility operated by or pursuant to a contract with the Indian Health Service) that provide family-centered care involving outpatient or ambulatory care (directly or through contracts or memoranda of understanding (MOUs) for WICY with HIV/AIDS. Women, infants, children, and youth living with HIV and their affected family members. Applicants should review the individual HRSA notice of funding opportunity (NOFO) issued under this Assistance Listing for any required proof or certifications which must be submitted prior to or simultaneous with submission of an application package. 45 CFR 75--Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards applies to this program. 2 CFR 200, Subpart E - Cost Principles applies to this program Preapplication coordination is required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. NOFOs for this listing will be posted on Grants.gov. HRSA requires all applicants to apply electronically through Grants.gov. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. 45 CFR 75--Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards applies to this program. HRSA requires all applicants to apply electronically through Grants.gov. Based on the recommendations of the objective review committee, the HRSA program official with delegated authority is responsible for final selection and funding decisions. Notification is made in writing by a Notice of Award (NOA). Contact the headquarters or regional location, as appropriate for application deadlines From 120 to 180 days. Approximately 6 months. Not applicable. Not applicable. Eligible applicants are reviewed by an objective review committee based on the criteria detailed in the NOFO. All funds must be expended solely for carrying out the approved project in accordance with the NOFO, the terms and conditions of the award, and the applicable cost principles. No more than 10 percent of total grant funds may be used for administrative costs. All indirect costs count toward this 10% limit. Funds may not be used for purchase, construction, or major alterations or renovations on any building or other facility; purchase or improvement of land; payments for clinical research; payments for nursing home care; cash payments to intended recipients of RWHAP services; research; foreign travel; to directly provide housing or health care services (e.g., HIV care, counseling and testing) that duplicate existing services; or for any item or service to the extent that payment has been made, or reasonably can be expected to be made, with respect to that item or service under any State compensation program, insurance policy, Federal or State health benefits program or by an entity that provides health services on a prepaid basis (except for a program administered by or providing the services of the Indian Health Services). Funds may also not be used towards PrEP or nPEP medications or medical services. As outlined in the June 22, 2016 RWHAP and PrEP program letter, the RWHAP legislation provides grant funds to be used for the care and treatment of people with HIV, thus prohibiting the use of RWHAP funds for PrEP medications or related medical services, such as physician visits and laboratory costs. However, RWHAP Part D funds can be used toward Psychosocial Support Services, a component of family-centered care, which may include counseling and testing and information on PrEP to eligible clients’ partners and affected family members, within the context of a comprehensive PrEP program. Additionally, the purchase of sterile needles or syringes for the purposes of hypodermic injection of any illegal drug is not allowable. Some aspects of Syringe Services Programs are allowable with HRSA's prior approval and in compliance with HHS and HRSA policy (see: https://www.aids.gov/federal-resources/policies/syringe-services-programs/). Performance Reports: Monitoring and reporting of HAB quality measures and work plan performance are incorporated into annual RWHAP Part D WICY non-competing continuation submissions and discussed during routine monitoring calls. A final performance report must be submitted 90 days after the end of the period of performance. In accordance with the provisions of 45 CFR 75--Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards, and 2 CFR 200, Subpart F - Audit Requirements, nonfederal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503 and 45 CFR 75. Recipients are required to maintain financial records for 3 years after the date they submit the final FFR. If any litigation, claim, negotiation, audit, or other action involving the award has been started before the expiration of the 3-year period, the records shall be retained until completion of the action and resolution of all issues, which arise from it, or until the end of the regular 3-year period, whichever is later. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Grants are typically awarded for up to a 3 year period of performance. Continued support, beyond the first year, is contingent upon satisfactory performance, the availability of Federal funds, and the continued best interest of the government. Supplemental grants may be funded for up to 1 year. Method of awarding/releasing assistance: Recipients draw down funds, as necessary, from the Payment Management System (PMS). PMS is the centralized web based payment system for HHS awards. Recipients draw down funds, as necessary, from the Payment Management System (PMS). PMS is the centralized web based payment system for HHS awards. None/Not specified. Mahyar Mofidi, Director, Division of Community HIV/AIDS Programs
5600 Fishers Lane, Room 9N18
Rockville, MD 20857 US
mmofidi@hrsa.gov
Phone: (301) 443-2075 http://www.ryanwhite.hrsa.gov 75-0350-0-1-550 (Project Grants) FY 22$0.00; FY 23 est $0.00; FY 24 est $68,500,000.00; FY 21$66,658,870.00; FY 20$67,147,778.00; FY 19$67,147,778.00; FY 18$67,147,778.00; FY 17$67,287,901.00; FY 16$63,903,447.00; - Ryan White HIV/AIDS Program (RWHAP) Part D Women, Infants, Children and Youth (WICY) Program(Project Grants) FY 22$69,077,889.00; FY 23 est $65,705,024.00; FY 24 est $3,000,000.00; FY 21$585,387.00; FY 20$3,000,000.00; FY 19$2,561,077.00; FY 18$3,117,376.00; FY 17$3,343,871.00; FY 16$2,717,295.00; - Project Grants - Ryan White HIV/AIDS Program Part D - Women, Infants, Children, and Youth (WICY) Grants Supplemental Funding FY 2022: $119,319 - $2,000,640; Average $605,898. FY 2022: Supplemental: $83,386 - $150,000. Supplemental awards are limited up to $150,000. HRSA awards are subject to the requirements of the HHS Grants Policy Statement (HHS GPS) that are applicable based on recipient type and purpose of award. The HHS GPS is available at https://www.hrsa.gov/grants. Not applicable.